Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950123-11-026605
Filing Date
2011-03-18
Accepted
2011-03-18 06:07:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 y04358bbe424b5.htm 424B5 342612
2 GRAPHIC y04358bbe0435801.gif GRAPHIC 4521
3 GRAPHIC y04358bby0435801.gif GRAPHIC 4521
  Complete submission text file 0000950123-11-026605.txt   356589
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-171615 | Film No.: 11696734
SIC: 2836 Biological Products, (No Diagnostic Substances)